ADXS insider trading
OTC Markets OTCPK HealthcareAdvaxis, Inc.: insider trade history from SEC Form 4 filings.
About Advaxis, Inc.
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers in Israel and the United States. The company is developing AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was incorporated in 1987 and is based in Monmouth Junction, New Jersey.
Company website: www.ayalapharma.com
ADXS insider activity at a glance
FilingIQ tracks 393 insider transactions for ADXS in filings since Jan 2, 2015. The most recent transaction is dated Feb 7, 2024.
Across the full history, 16 open-market purchases
and 42 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest ADXS Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ADXS?
- FilingIQ tracks 393 Form 4 insider transactions for ADXS (Advaxis, Inc.), covering filings from Jan 2, 2015 onwards. 0 of those are dated within the last 90 days.
- Are ADXS insiders net buyers or net sellers?
- Across the full Form 4 history for ADXS, 16 transactions (4%) were open-market purchases and 42 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ADXS insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is ADXS in?
- Advaxis, Inc. (ADXS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $25.71M.
Methodology & sources
Every ADXS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.